Company news

 

Please visit us at the American Society of Cataract and Refractive Surgeons meeting in San Francisco. The meeting will take plan at the Moscone Center from April 3 to 8. We will be presenting at booth 3002 and look forward to seeing you there.

 

 

 

 

Other news

 

FDA clearance pending for the EndoShield DSEK graft injector.

 

 

 

Welcome

 

 

Welcome to keramed online

 

KeraMed Inc. is a company devoted to developing innovative solutions for treatment of corneal disease. Our first product is the Endoshield DSEK Graft Injector. This patent pending device allows one-handed atraumatic insertion of a 9 mm DSEK graft through a sub-4 mm clear corneal incision.

 

Benefits of using this sterile single use device include:

  • Faster recovery time for the patient because of the small incision size
  • Better vision because of less induced corneal astigmatism